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Abstract
BACKGROUND: The aim of the study was to evaluate whether there is any association between myocardial ischemia, common 
risk factors and carotid artery ultrasound parameters in asymptomatic type 2 diabetic (DMT2) patients.
MATERIAL AND METHODS: 60 asymptomatic DMT2 patients (pts) without known coronary artery disease (CAD) underwent 
one day rest Dypiridamole stress Tc-99m sestamibi single photon emission computed tomography myocardial perfusion 
scintigraphy (MPS). We used 17 segment models for perfusion analysis with the assessment of perfusion scores. Patients 
were studied for age, sex, hypertension, hyperlipidemia, hs-CRP, smoking, obesity and family history of cardiac disease. Color 
Ultrasound examination of carotid arteries was performed in all patients.
RESULTS: 51 patients (pts) had hypertension, 48 pts had hyperlipidemia, 15 were smokers, 6 pts had BMI > 30 kg/m2 and 
26 patients had positive family history for CAD. 18 (31%) patients had myocardial ischemia. Mild ischemia was found in 6 pts, 
moderate in 7 patients and severe ischemia in 5 patients. Carotid IMT was increased in 34 pts and 15 pts had carotid plaques. 
Mean c-IMT value in patients with normal MPS results was 0.7 ± 0.1; in moderate ischemia 0.9 ± 0.1 and in pts severe ischemia 
1.0 ± 0.2. Multivariate analysis showed obesity, low HDL and increased diastolic blood pressure predictors of increased c-IMT. 
Increased pulse pressure (PP), age and non-HDL cholesterol were predictors for presence of carotid plaques. Multivariable 
analysis for prediction of stress induced ischemia showed OR 2.9 (95% CI 2.1−5.1) for male gender, OR 3.1 for systolic blood 
pressure (95% CI 1.9–3.8) and OR 2.8 for LDL cholesterol (95% CI 1.7−3.6).
CONCLUSIONS: Our study has shown high prevalence of traditional risk factors and silent myocardial ischemia in type 2 diabetic 
patients, with the importance of SPECT imaging in selected diabetes type 2 patients. The study highlights the importance of 
screening for carotid atherosclerosis, which may be useful to identify diabetic patients at higher risk for coronary artery disease.. 
KEY words: myocardial perfusion scintigraphy, carotid artery disease, myocardial ischemia, risk factors
Nucl Med Rev 2017; 20, 1: 3–9
Background
Type 2 diabetes (DMT2) is an established risk factor for in-
creased cardiovascular events. A two- to four-fold increased risk 
of CVD in people with diabetes compared with non-diabetic pop-
ulation has been reported by various studies [1, 2]. The scientific 
literature data estimates the prevalence of silent myocardial 
ischemia (SMI) in DMT2 between 15–59%. Approximately 40% 
of the DMT2 population had silent myocardial infarction, which 
might lead to sudden cardiac death [3, 4]. There was a long 
debate regarding the best way to screen asymptomatic diabetic 
patients for significant CAD [4]. Diabetes has been defined 
as an independent factor for progression of atherosclerosis, 
measured by rise in carotid intima-media thickness (c-IMT), 
but also for the presence of high grade carotid stenosis. Dia-
betes is linked to endothelial dysfunction, insulin resistance, 
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vascular inflammation, diffuse atherosclerosis and increased 
thrombotic risk. Although atherosclerosis is a pathological po-
livascular process, a non-invasive ultrasonography evaluation 
of carotid arteries enables more precise estimate of the overall 
progression of atherosclerosis and improves cardiovascular risk 
profile. It was previously reported that c-IMT is closely related 
to the incidence of cerebrovascular disease and CAD in elderly 
subjects and diabetic patients as well [5, 6]. There are not many 
studies assessing the relationship of risk factors, increased 
c-IMT, carotid plaques and presence of myocardial ischemia in 
diabetic patients. The aim of this study was to evaluate the risk 
factor profile, presence of asymptomatic carotid artery disease 
and predictors of CAD in a group of asymptomatic DMT2 pa-
tients screened for myocardial ischemia.
Material and methods
Study design and protocol
Our study is designed as a nonrandomized cross sectional 
clinical study. The study evaluated 60 consecutive asymptomatic 
patients with DMT2 (34 male, 26 female; age range of 67 ± 6 years), 
without previously known or established CAD were included in the 
study. All patients filled out the World Health Organization (WHO) 
Rose Angina Questionnaire for confirmation of the asymptomatic 
status. Screening for myocardial ischemia was performed using 
MPI SPECT imaging in the nuclear cardiology laboratory at our 
clinic. Color Doppler ultrasound of carotid arteries was performed 
in the vascular lab by experienced physicians, who were not aware 
of patient’s history and MPI findings.
This study is as a part of the doctoral research thesis data, 
approved by the Ethical Committee of Medical Faculty, University 
St. Cyril and Methodius in Skopje, Macedonia. 
Physical examination was performed in all patients which 
also included blood pressure measurement, weight, height, body 
mass index (BMI) and risk factors analysis. Full blood laboratory 
analyses with HDL, LDL, non-HDL and triglyceride, fasting glucose 
levels, HbA1C (%) levels were performed within a maximum of 
2 weeks prior to MPI study. Clinical and laboratory characteristics 
are shown in Table 1. The following inclusion criteria were used: 
asymptomatic patients with DMT2; exclusion criteria were typical 
stable angina pectoris, previously known or established as CAD 
(history of myocardial infarction, acute coronary syndromes, previ-
ous percutaneous intervention or coronary artery bypass surgery), 
LVEF < 50% at rest, severe valvular disease, atrial fibrillation, left 
bundle branch block, presence of pace maker, severe chronic 
pulmonary disease. 
Physical examination and full disease history was taken on 
the day of MPS performance. Blood pressure was measured after 
5 minutes rest in sitting position in all patients. Pulse pressure (PP) 
was calculated as PP = systolic blood pressure (SBP) − diastolic 
blood pressure (DBP). Laboratory examination was performed in all 
patients 2 ± 1 week before MPS study and it included the following 
parameters: full blood count, fasting glucose level, HbA1c%, BUN, 
creatinin, electrolytes — sodium and potassium, AST, ALT, fasting 
lipids values-cholesterol, LDL, HDL, triglyceride, non-HDL choles-
terol. High sensitive CRP (hs-CRP) was evaluated quantitatively 
with high sensitivity assay, imunoturbidimetric Abbot ARCHITECT 
c8000 analyzer, with analytical sensitivity 0.15–15 mg/l. The following 
hs-CRP values were used for CV risk prediction: < 1 mg/L — low 
risk; 1–3 mg/L moderate risk; > 3 mg/L high risk.
Definition of study variables
Risk factor definitions were made according to the most recent 
ESC guidelines on hypertension, hyperlipidemia and cardiovascular 
prevention: arterial hypertension (systolic blood pressure (SBP) > 140 bpm 
or diastolic BP > 90 bpm), hyperlipidemia (LDL > 1.8 mmol/l for 
diabetic patients; high-density lipoprotein < 1.1 and 1.0 mmol/l 
for women and man respectively and triglycerides > 1.7 mmol/l), 
family history (MI or sudden cardiac death in an immediate male 
relative < 55 years or female < 65 years), smoker (current smoker 
or those who quit in the past 6 months). BMI ≥ 30 kg/m² was used to 
define obese patients. Type 2 diabetes mellitus was defined as es-
tablished disease in patients treated with oral antidiabetic medication 
or insulin following initial treatment with oral anti-diabetic therapy. 
Newly diagnosed diabetes was defined as having either one of the 
following criteria, base on the ESC guidelines on prediabetes and 
diabetes: fasting glucose of 7.0 mmol/L or non-fasting glucose 
11.0 mmol/L in 2 separate samples, HbA1c > 6.5% or pathologic 
OGTT in patients with fasting glucose over 6.5 without previously 
known or treated diabetes. 
Myocardial perfusion SPECT imaging (MPI)
MPI SPECT imaging was performed using one day rest 
stress protocol with radiotracer Tc-99m sestamibi, using 15 mCI for 
the rest and 25 mCI for the stress study. We used single head gam-
ma camera Siemens e-cam, with commercially available quantita-
tive gated and perfusion SPECT software package (4DM-SPECT). 
Patients were instructed to refrain from caffeine-containing bev-
erages for at least 12 h, nitrates for 24 h and beta-blockers for 
48 h before the study. All patients underwent pharmacological 
stressing with Dipyridamole. We used the 17-segment model for 
quantitative Bull’s eye analysis of regional myocardial perfusion 
and function. Myocardial perfusion was assessed by 5 point score 
system (0 — normal radiotracer uptake; 1 — mild, 2 — moderate; 
3 — severe hypoperfusion; 4 — absent uptake). Semi quantitative 
analysis of regional perfusion at rest and stress was performed 
Table 1. Clinical characteristics of the study population
Variables                                       Mean values Standard  
deviation
Systolic pressure [mm Hg]                 154.9 17.3
Diastolic pressure [mm Hg]                                            85.3 8.9
Pulse pressure [mm Hg]                      65 11.0
Weight [kg]                                          83.5 12.2
Height [cm]                                                                   171.6 6.2  
BMI [kg/m2]                                          27.3 3.6    
Total cholesterol [mmol/L]                          5.5 1.3   
HDLcholesterol [mmol/L]                                      0.9 0.5
Non-HDLcholesterol [mmol/L]                 4.1 1.2
LDLcholesterol [mmol/L]                        3.6 1.1
Triglycerides [mmol/L]                             2.2 0.9
hs-CRP                                                  2.1 1.5
BMI — body mass index; HDL — high-density lipoprotein; LDL — low-density lipoprotein
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using summed stress score (SSS), summed rest score (SRS) and 
summed differential score (SDS), aimed to assess the presence 
and extend of myocardial ischemia. Scan abnormalities were de-
fined as follow: SSS < 4 normal perfusion; 4–8 mild; 9–13 moder-
ate; > 13 severely abnormal scan. SDS < 6 mild (< 10% of LV); 
SDS 7–10 moderate (10–15% of LV); SDS > 10 severe ischemia 
(> 15% of LV). Any perfusion abnormality was defined as SDS > 4 
and/or SRS > 4. Regional wall motion analysis was assessed by 6 
point scoring system at rest and stress (0 — normal wall motion, 
1 — mild, 2 — moderate; 3 — sereve hypokinesia, 4 — akinesia, 
5 — dyskinesia) using wall motion score index. 
Color Doppler carotid ultrasound
All patients underwent a two-dimensional echo-color Doppler 
examination of carotid arteries bilaterally using a high-definition 
vascular echo machine (Philips HD11XE). The Mannheim carotid 
intima-media thickness consensus (2004/2006/2011) defined evalu-
ation criteria of intima-media thickness (IMT) and atherosclerotic 
plaques. IMT was measured in 10mm segment at end diastole, 
proximal from carotid bulbe in the internal carotid artery, carotid 
bifurcation and the proximal part of the internal carotid artery bilat-
erally. Carotid IMT > 0.8 mm was defined as abnormal. The pres-
ence of atherosclerotic plaques can be diagnosed by detection 
of an IMT > 1.3 mm or a focal structure emerging from the wall 
of at least 0.5 mm or 50% of the surrounding IMT value. Carotid 
stenosis greater than 60% was considered significant.
Statistical analysis
Statistical analysis was performed with the use of the SPSS 
statistical package (version 18.0). Categorical variables were 
compared using chi-square test and continuous variables using 
unpaired Student t test. Categorical values were expressed in per-
centages, continued as mean value ± SD. We applied the Pearson 
method for correlations assessment. Linear regression analy-
sis was used to determine whether there was a correlation between 
the carotid ultrasound findings and MPI perfusion abnormalities. 
Multivariate forward stepwise logistic regression analysis was built 
in order to identify factors associated independently with the pres-
ence of silent myocardial ischemia and carotid atherosclerosis. 
The analysis includes inflammation biomarker hs-CRP, clinical risk 
factors and carotid ultrasound parameters. The prevalence of mild 
ischemia (SDS 4–7) and severe ischemia (SDS > 7) was compared 
between patients with normal and increased c-IMT. The criterion 
for entrance into the model was a univariate probability value of 
p < 0.05 and p > 0.10 for removal from the model. P < 0.05 
was found to be statistically significant for all statistical tests.
Results
Studied population consisted of 34 male (56.6%) and 26 female 
patients (43.3%), with mean age of 65 ± 6 years, respectively, 
as shown in Table 1. The prevalence of traditional risk factors and 
laboratory findings are presented in Table 1 and 2. All patients had 
on average 2 risk factors. The risk factors for the cardiovascular dis-
ease were distributed as follows: 76% of systemic arterial hyperten-
sion; 51.6% of hyperlipidemia; 13.3% of cigarette-smoking, 11.6% 
with obesity and 43.3% of family history for coronary history. Average 
duration of diabetes was 8 ± 3 years. 11 patients (18.3%) used 
insulin therapy. The average hs-CRP values were 2.1 ± 1.5 mg/L.
Myocardial SPECT findings
The stress phase was carried out through pharmacological 
stress with dipyridamole in all patients. Total of 1020 segments were 
analyzed. All patients hadnormal rest left ventricular function with 
EF > 55% assessed by Gated SPECT. The scintigraphy results were 
abnormal in 21 patients (35%). Stress inducible ischemia was found 
in 18 pts (30%). Mild ischemia was found in 6 patients (10%) 
— summed stress score (SDS) < 4, moderate ischemia (SDS 
7–10) in 7 patients (11.6%) and severe ischemia (SDS > 10) in 
5 patients (8.3%) (Figure 1). Two patients had reversed perfusion 
defects and one patient fixed perfusion defect in one segment. 
We compared scintigraphy data against common cardiovas-
cular risk factors. We found significant correlation between de-
gree of myocardial ischemia and mean value of c-IMT (r = 0.62, 
p < 0.001), hyperlipidemia (r = 0.69, p < 0.001) and systolic BP 
(r = 0.52, p < 0.05). We found that the patients with abnormal MPI 
result were mainly older male population (p = 0.01), comparing 
to the group with normal MPI results. Among the 18 patients with 
scintigraphy myocardial ischemia findings, all had at least 2 risk 
factors: 10 (55.5%) had 2 risk factors, 6 (33.3%) had 3 risk fac-
tors and 2 (11.1%) had 4 risk factors. Among the 42 patients with 
normal scintigraphy: 25 (59.5%) had 2 risk factors, 15 (35.7%) had 
3 risk factors. Association between moderate and severe ischemia 
and c-IMT is shown in Figure 2. 
Table 2. Clinical characteristics of patients with and without myocardial ischemia
Variables Patients 
n = 60
MPI ischemia  
n = 18
Normal MPI 
n = 42
p value
Age 65 ± 6 69 ± 3 64 ± 2 < 0.05
Gender 34 m/26 f 41 m/19 f 36 m/24 f < 0.01
Hypertension 45 (76%) 28 17 < 0.001
Hyperlipidemia 31 (51.6%) 20 11 < 0.01
Obesity   7 (11.6%) 3 4    0.067
Family hist CAD 26 (43.3%) 12 13    0.071
Active smoker   8  (13.3%) 4 4    0.079
CAD — coronary artery disease; MPI — myocardial perfusion imaging
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Multivariable analysis for prediction  
of myocardial ischemia
We have performed initial univariate analysis for prediction of 
myocardial ischemia in DMT2 patients which includes the following 
parameters: age, gender, systolic BP, diastolic BP, pulse pressure, 
cholesterol, LDL, HDL, triglycerides, non-HDL, BMI > 30 kg/m2, 
smoking, hs-CRP, family history of CAD, mean c-IMT, presence 
of carotid plaques. After adjustment for age, male gender, LDL 
cholesterol and hypertension in multivariate model, increased 
c-IMT remained a significant predictor of SDS (p < 0.001) (OR 
3.811 [95% CI 2.251–5.963]). Multivariate analysis showed male 
gender, systolic blood pressure, LDL cholesterol and increased 
mean c-IMT independent predictors for presence of myocardial 
ischemia (Table 3). 
Carotid ultrasound findings
Clinical characteristics of the study cohort in relation to the 
carotid ultrasound findings are shown in Table 4. Normal c-IMT 
(< 0.8 mm) was found in 26 patients (43.3%), while in the remaining 
34 patients (56.5%), c-IMT was present in one of the common ca-
rotid arteries. The majority of patients with increased c-IMT and ca-
rotid plaques were older pts with hypertension and hyperlipidemia. 
c-IMT findings in relation to the extent  
of SPECT myocardial ischemia
We found the increase in mean c-IMT parallel with the degree 
of myocardial ischemia (Table 5). The mean SDS increased from 
2.4 ± 1.1 in patients with normal c-IMT to 8.5 ± 1.3 in patients with 
increased c-IMT (p < 0.001). Results of multivariate regression 
analysis are shown above, with c-IMT remained a significant predic-
tor of myocardial ischemia in the multivariate model (p < 0.001).
c-IMT findings in relation to prevalence  
of abnormal SPECT results
We found abnormal myocardial perfusion results in 11% of pa-
tients with normal c-IMT. In contrast, 81% of patients with abnormal 
MPI results and myocardial ischemia findings had increased c-IMT. 
Figure 1. Scintigraphic findings in studied population
Figure 2. Association between moderate and severe ischemia and 
c-IMT
Table 3. Stepwise logistic regression analysis for predictors of myocardial ischemia
B S.E. Wald df Sign OR 95% CI
Male gender 1.965 0.791 5.487 1 0.000 2.947 2.198 5.125 
BPs  1.042 0.633 6.285 1 0.000 3.126 1.934 3.857 
LDL 1.891 1.157 7.163 1 0.000 2.880 1.756 3.668 
c-IMT 1.945 1.264 6.261 1 0.000 3.811 2.251 5.963
BPs — systolic blood pressure; LDL — low density holesterol; c-IMT — carotid intima media thickness
Table 4. Clinical characteristics of the study population in relation to 
carotid ultrasound findings
Variables IMT < 0.8  
n = 26
IMT > 0.8  
n = 34
Plaques  
n = 15
Age 69 ± 4 64 ± 4 68 ± 2
Gender 24 m; 16 f 24 m; 16 f 11 m; 8 f
Hypertension 6 (54.5%) 26 (76.4%) 13 (86.6%)
Pulse pressure 66 ± 5 68 ± 5 69 ± 6
Hyperlipidemia 7 (63.6%) 22 (53.6%) 9 (60.0%)
Obesity 2 (18.1%) 3 (8.8%) 2 (13.3%)
Fam history CAD 9 (81.8%) 3 (8.8%) 5 (33.3%)
Active smoker / 4 (11.7%) 4 (3.7%)
CAD — coronary artery disease
 P
at
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%
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c-IMT normal
30
25
20
15
10
5
0
5%
c-IMT increased
25%
Normal
Mild ishemia
Moderate ishemia
Severe ishemia
70%
8%
12%
10%
7www.nmr.viamedica.pl
Irena Peovska Mitevska et al., Prevalence of risk factors and asymptomatic carotid atherosclerosis
Original
Our study showed the prevalence of moderate and severe ischemia 
increased from 4.5% in patients with normal c-IMT values to 25% in 
patients with increased mean c-IMT values (Figure 2).
Parameters predictors of increased c-IMT  
and carotid plaques 
Multivariate analysis showed obesity, low HDL and diastolic 
blood pressure independent predictors for increased mean c-IMT 
(Table 6) and non-HDL, age and pulse pressure as independent 
predictors for presence of carotid plaques (Table 7). 
Discussion
Silent myocardial ischemia — SMI is the most common 
manifestation of ischemic heart disease — IHD. 75% of ischemic 
episodes are asymptomatic and 48% of these patients have only 
one or even none of the traditional risk factors [1–3]. Diabetes, 
hypertension, previous myocardial infarction, surgical revascu-
larization and advanced age are presumed risk factors for silent 
ischemia, even though many patients do not have any apparent 
risk factors and seem to be totally asymptomatic [4, 6]. In clinical 
practice it is difficult to identify subjects with a high risk of SMI 
among an asymptomatic population.The rationale for identifying 
SMI is that this disorder is associated with an increase in coro-
nary risk. All this data urge a demand for effective screening to 
reduce the risk of unexpected coronary events by sophisticating 
individual risk. The biggest scientific evidence for the prevalence 
of SMI comes from MPI studies, which report the SMI prevalence 
of 15–63% depending of the criteria used, study population and 
protocols [4, 6]. 
The ongoing debate on the prognostic relevance of SMI 
screening in the era of modern intensive medical therapy caused 
many controversies among consensus documents of the American 
Diabetes Association (ADA) and European Society of Cardiology 
(ESC) and European Association for the study of Diabetes (EASD) 
concerning the screening for CAD in asymptomatic diabetic 
population. CAD is the leading cause of mortality and morbidity in 
DMT2 patients [5]. The asymptomatic phase of CAD in DMT2 pa-
tients causes difficulty in CAD detection. There are several prospec-
tive studies that have shown the value of SPECT MPI in detection 
of myocardial ischemia, with the prevalence of moderate to severe 
grade ischemia in 6-8% patients. Our study includes high number 
of patients with hypertension and hyperlipidemia and lower propor-
tion of obese patients (11.6%). Myocardial ischemia was found in 
18 patients (30%) in our study. These results correspond well with 
those reported in the literature [14–16]. Mild ischemia was found 
in 6 patients (10%), moderate ischemia in 7 patients (11.6%) and 
severe ischemia in 5 patients (8.3%). Our multivariate regression 
analysis show independent predictors for SMI male gender, systolic 
blood pressure and LDL cholesterol. In DIAD study, independent 
predictive factor was diabetic neuropathy [10]. Zellweger et al., 
who analyzed 3664 asymptomatic patients without known CAD 
history using SPECT MPI, observed that 7.5% ischemic myocardium 
was related to high risk factors [15]. Scholte et al., found  inde-
pendent predictors of ischemia smoking, diabetes duration and 
cholesterol/HDL ratio [16]. This discrepancy in SMI predictors might 
be caused by the other factors characteristic for the development 
of diabetic micro vascular and macro vascular complications, such 
as genetic and still understudied markers. 
Ultrasonographic measurement of carotid IMT allows the non-
invasive and early detection of atherosclerotic changes and is used 
as a noninvasive end point for assessing the progression and 
regression of atherosclerosis in clinical trials [18]. In patients with 
a history of cardiovascular event, IMT correlates linearly with overall 
and cardiac mortality [20]. 
Table 5. The association between the carotid artery ultrasound 
parameters and the severity of SPECT myocardial ischemia in the 
cohort study 
Variables Normal MPS 
result  
n = 42
Mild  
ischemia  
n = 6
Moderate  
ischemia  
n = 7
Severe  
ischemia 
n = 5 
c-IMT 0.71 ± 0.20 0.81 ± 0.1 0.90 ± 0.1 1.00 ± 0.2
Plaques 11 (21.4%) 2/6 3/7 3/5
c-IMT — carotid artery intima media thickness
Table 6. Stepwise logistic regression analysis for predictors of increased c-IMT 
B S.E. Wald df Sign OR 95% CI
Obesity 1.835 0.251 5.260 1 0.000 2.931 1.688 5.127 
Low HDL 1.122 0.423 7.479 1 0.000 2.486 1.734 3.566 
BPd 1.343 1.587 7.325 1 0.002 3.127 1.946 4.198
Abbreviations: BPd — diastolic blood pressure; HDL — high density lipoprotein
Table 7. Stepwise logistic regression analysis for predictors of carotid plaques
   B S.E. Wald df Sign OR 95% CI
Non-HDL 1.285 0.321 4.470 1 0.000 3.132 2.398 6.158 
Age 1.042 0.543 6.599 1 0.000 2.786 1.721 3.567 
PP 1.567 1.792 7.323 1 0.000 2.937 1.954 3.268
PP — pulse pressure; HDL — high density lipoprotein
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The presence of carotid artery plaques correlates with the 
presence and extent of significant CAD, older age and the pres-
ence of diabetes and left ventricular hypertrophy [21]. According 
to Boucher et al., IMT values < 0.55 mm are associated with 
a negative predictive value of 80% for abnormal SPECT results; in 
nonsmokers the value is > 90% [22]. In our study, the increased 
c-IMT was a strong predictor of the extent of myocardial ischemia. 
Normal c-IMT values were associated with a low risk of presence 
of abnormal scintigraphic result. Only three asymptomatic diabetic 
patients with normal CIMT values had severely abnormal perfusion 
(5%). However, it must be underlined that our study group had 
mean 2 risk factors and may represent a more high-risk population 
than the general asymptomatic DMT2 patients. Our multivariable 
analysis shows independent predictors for the increased mean 
c-IMT obesity, obesity, low HDL cholesterol and diastolic blood 
pressure. Independent predictors for carotid plaques pres-
ence were age, non- HDL cholesterol and pulse pressure (PP). 
Previous studies reported PP as a predictor of acute coronary 
events and as an independent risk factor for stroke [21, 22]. 
Mean c-IMT value increased with the ischemia severity on MPI 
imaging. Our study confirms that the increased c-IMT is linked 
to an increased likelihood of CAD presence in asymptomatic 
DMT2 patients.
The Atherosclerosis Risk in Communities (ARIC) study reported 
statistically significant associations of change in CIMT with baseline 
diabetes, current smoking, HDL cholesterol, pulse pressure, white 
blood cell count and fibrinogen [32]. Data from the Rotterdam study 
indicated that moderate in severe progression of c-IMT was related 
to age, body mass index, male sex, current smoking, systolic blood 
pressure and the presence of hypertension [33]. 
Our study emphasizes  the clinical value of SPECT myocar-
dial imaging for detection of SMI in selected diabetes type 2 
patients with at least two risk factors and increased c-IMT, which 
might influence further patient management.
Study limitations
The small sample we evaluated could represent a limitation 
of our study. However, our results could help to improve our un-
derstanding of the relationship between risk factors, carotid artery 
atherosclerosis and coronary function in asymptomatic DMT2 
patients screened for myocardial ischemia. 
Conclusions
Our study showed significant relation between c-IMT, risk fac-
tors and the presence of myocardial ischemia in asymptomatic 
patients with DMT2 detected by SPECT myocardial perfusion imag-
ing. The high prevalence of SMI in high risk patients underlines the 
importance for CAD screening in highly selected DMT2 individuals, 
both for improving the quality of life and long term survival. Multi-
variate analysis showed male gender, systolic blood pressure, LDL 
cholesterol and increased mean c-IMT independent predictors for 
presence of myocardial ischemia.
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